Forte Biosciences, Inc. Financial Ratios
FBRX|FY2019 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2019 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2019)
Return on Equity
-67.0%
Profit Margin
-94948.8%
Net Income / Revenue
Asset Turnover
0.00
Revenue / Total Assets
Equity Multiplier
0.48
Total Assets / Equity
Composite: -67.0% (reported: -67.0%)
Profitability
Liquidity
Current Ratio
1.74
Quick Ratio
1.74
Solvency
Interest Coverage
-16.11
Efficiency
Asset Turnover
0.00
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2019 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-11.9%
-8.1pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.